Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines

Zarkavelis, G.; Amylidi, A. L.; Verbaanderd, C.; Cherny, N. I.; Metaxas, Y.; Vries, E. G. E. de; Zygoura, P.; Amaral, T.; Jordan, K.; Strijbos, M.; Dafni, U.; Latino, N.; Galotti, M.; Lordick, F.; Giuliani, R.; Pignatti, F.; Pentheroudakis, G.

dc.contributor.author	Amaral, Teresa
dc.date.accessioned	2024-05-14T09:24:43Z
dc.date.available	2024-05-14T09:24:43Z
dc.date.issued	2023
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/153345
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2022.100604	de_DE
dc.subject.ddc	610	de_DE
dc.title	Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_02187
utue.personen.roh	Zarkavelis, G.
utue.personen.roh	Amylidi, A. L.
utue.personen.roh	Verbaanderd, C.
utue.personen.roh	Cherny, N. I.
utue.personen.roh	Metaxas, Y.
utue.personen.roh	Vries, E. G. E. de
utue.personen.roh	Zygoura, P.
utue.personen.roh	Amaral, T.
utue.personen.roh	Jordan, K.
utue.personen.roh	Strijbos, M.
utue.personen.roh	Dafni, U.
utue.personen.roh	Latino, N.
utue.personen.roh	Galotti, M.
utue.personen.roh	Lordick, F.
utue.personen.roh	Giuliani, R.
utue.personen.roh	Pignatti, F.
utue.personen.roh	Pentheroudakis, G.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article 100604	de_DE
dcterms.isPartOf.ZS-Volume	8 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE